相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images
Musib Siddique et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
A semipopulation input function for quantifying static and dynamic 18F-fluoride PET scans
Glen Mervyn Blake et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Remodeling markers are associated with larger intracortical surface area but smaller trabecular surface area: A twin study
Ashild Bjornerem et al.
BONE (2011)
Differential Effects of Teriparatide on Regional Bone Formation Using 18F-Fluoride Positron Emission Tomography
Michelle L. Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Precision and Sensitivity of 18F-Fluoride PET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods
Musib Siddique et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
The Epidemic of Hip Fractures: Are We on the Right Track?
Klaas A. Hartholt et al.
PLOS ONE (2011)
Quantitative Computed Tomographic Assessment of the Effects of 24 Months of Teriparatide Treatment on 3D Femoral Neck Bone Distribution, Geometry, and Bone Strength: Results From the EUROFORS Study
Jan Borggrefe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Cortical bone: a target for fracture prevention?
David B. Burr
LANCET (2010)
Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study
Roger M. D. Zebaze et al.
LANCET (2010)
Differences in regional bone perfusion and turnover between lumbar spine and distal humerus: 18F-fluoride PET study of treatment-naive and treated postmenopausal women
Michelle L. Frost et al.
BONE (2009)
Hip Fractures and the Contribution of Cortical Versus Trabecular Bone to Femoral Neck Strength
Gerold Holzer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Effects of Alendronate on Bone Metabolism in Glucocorticoid-Induced Osteoporosis Measured by 18F-Fluoride PET: A Prospective Study
Kenzo Uchida et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: A perspective
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model
W. K. Hsu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice
D. J. Leeming et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis
DC Bauer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Teriparatide [PTH(I-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity
M Sato et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis
ML Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography
ML Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
JR Zanchetta et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis
AB Hodsman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure
YB Jiang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Quantification of skeletal kinetic indices in Paget's disease using dynamic 18F-Fluoride positron emission tomography
GJR Cook et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys
DB Burr et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Quantitative studies of bone with the use of F-18-fluoride and Tc-99m-methylene diphosphonate
GM Blake et al.
SEMINARS IN NUCLEAR MEDICINE (2001)
Effect of parathyroid hormone on cortical bone response to in vivo external loading of the rat tibia
H Hagino et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2001)
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers
ES Kurland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
分享论文
